NKGen Biotech COO Pierre Gagnon resigns, stays as advisor through Nov 30

NKGen Biotech, Inc.

Pierre Gagnon resigned as COO effective August 15, 2024; will remain as non-executive employee in transition role until November 30, 2024.
Resignation not due to any disagreements with the Company regarding operations, policies, or practices.
No successor has been named as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Pierre Gagnon

Chief Operating Officer

NKGen Biotech, Inc.

Effective: 2024-08-15
Filed: August 21, 2024, 7:59 PM ET

On August 15, 2024, Pierre Gagnon, who currently serves as Chief Operating Officer of NKGen Biotech, Inc. (the “Company”), notified the Company of his intent to resign from his role as Chief Operating Officer and as an officer of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Pierre Gagnon resigned as Chief Operating Officer at NKGen Biotech, Inc..

Action: resigned
Role: Chief Operating Officer

Exact text from the filing

On August 15, 2024, Pierre Gagnon, who currently serves as Chief Operating Officer of NKGen Biotech, Inc. (the “Company”), notified the Company of his intent to resign from his role as Chief Operating Officer and as an officer of the Company, effective immediately.

View on SEC.gov

Source: SEC EDGAR

accession 0001213900-24-071450

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.